Mark F. Gourley

3.2k total citations
35 papers, 2.4k citations indexed

About

Mark F. Gourley is a scholar working on Immunology, Rheumatology and Epidemiology. According to data from OpenAlex, Mark F. Gourley has authored 35 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 16 papers in Rheumatology and 6 papers in Epidemiology. Recurrent topics in Mark F. Gourley's work include Systemic Lupus Erythematosus Research (13 papers), T-cell and B-cell Immunology (13 papers) and Immune Cell Function and Interaction (6 papers). Mark F. Gourley is often cited by papers focused on Systemic Lupus Erythematosus Research (13 papers), T-cell and B-cell Immunology (13 papers) and Immune Cell Function and Interaction (6 papers). Mark F. Gourley collaborates with scholars based in United States and Somalia. Mark F. Gourley's co-authors include Arthur Μ. Krieg, Alfred D. Steinberg, George C. Tsokos, Christine Castro, Yuang‐Taung Juang, D M Klinman, Eri Hagiwara, Frederick W. Miller, András Perl and Dennis M. Klinman and has published in prestigious journals such as Annals of Internal Medicine, The Journal of Immunology and The FASEB Journal.

In The Last Decade

Mark F. Gourley

34 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark F. Gourley United States 22 1.4k 1.1k 409 358 317 35 2.4k
Ruud J.T. Smeenk Netherlands 28 2.0k 1.5× 1.4k 1.3× 253 0.6× 410 1.1× 272 0.9× 66 3.1k
Yair Molad Israel 25 959 0.7× 725 0.7× 252 0.6× 415 1.2× 178 0.6× 70 2.1k
Tomonori Ishii Japan 28 864 0.6× 747 0.7× 261 0.6× 640 1.8× 311 1.0× 153 2.8k
Arthur I. Grayzel United States 24 903 0.7× 559 0.5× 331 0.8× 463 1.3× 275 0.9× 43 1.9k
G. Hauptmann France 31 525 0.4× 1.6k 1.5× 264 0.6× 376 1.1× 149 0.5× 114 2.5k
Woodruff Emlen United States 22 984 0.7× 1.0k 0.9× 168 0.4× 422 1.2× 135 0.4× 31 2.0k
Damian Kraus United States 15 814 0.6× 1.2k 1.1× 463 1.1× 269 0.8× 69 0.2× 18 2.0k
Federico Pratesi Italy 27 961 0.7× 1.1k 1.0× 110 0.3× 653 1.8× 159 0.5× 71 2.3k
Hiroaki Ida Japan 30 1.1k 0.8× 1.3k 1.2× 108 0.3× 1.0k 2.9× 413 1.3× 165 3.3k
Carlos Alberto von Mühlen Brazil 26 1.2k 0.9× 682 0.6× 78 0.2× 497 1.4× 592 1.9× 56 2.4k

Countries citing papers authored by Mark F. Gourley

Since Specialization
Citations

This map shows the geographic impact of Mark F. Gourley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark F. Gourley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark F. Gourley more than expected).

Fields of papers citing papers by Mark F. Gourley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark F. Gourley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark F. Gourley. The network helps show where Mark F. Gourley may publish in the future.

Co-authorship network of co-authors of Mark F. Gourley

This figure shows the co-authorship network connecting the top 25 collaborators of Mark F. Gourley. A scholar is included among the top collaborators of Mark F. Gourley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark F. Gourley. Mark F. Gourley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schiffenbauer, Adam, Christine Castro, Galen O. Joe, et al.. (2017). A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis. Seminars in Arthritis and Rheumatism. 47(6). 858–864. 46 indexed citations
2.
Steinberg, Alfred D., et al.. (2015). Approach to Lupus Nephritis Based upon Randomized Trials. Contributions to nephrology. 99. 46–54.
3.
OʼHanlon, Terrance P., Zhuoyan Li, Lu Gan, et al.. (2011). Plasma proteomic profiles from disease-discordant monozygotic twins suggest that molecular pathways are shared in multiple systemic autoimmune diseases*. Arthritis Research & Therapy. 13(6). R181–R181. 13 indexed citations
4.
Dagur, Pradeep K., Mark F. Gourley, Leigh Samsel, et al.. (2009). CD146+ T lymphocytes are increased in both the peripheral circulation and in the synovial effusions of patients with various musculoskeletal diseases and display pro‐inflammatory gene profiles. Cytometry Part B Clinical Cytometry. 78B(2). 88–95. 26 indexed citations
5.
Gourley, Mark F. & Frederick W. Miller. (2007). Mechanisms of Disease: environmental factors in the pathogenesis of rheumatic disease. Nature Clinical Practice Rheumatology. 3(3). 172–180. 67 indexed citations
6.
Slattery, Marcia J., Billinda Dubbert, Albert J. Allen, et al.. (2004). Prevalence of Obsessive-Compulsive Disorder in Patients With Systemic Lupus Erythematosus. The Journal of Clinical Psychiatry. 65(3). 301–306. 38 indexed citations
7.
Juang, Yuang‐Taung, Klaus Tenbrock, Madhusoodana P. Nambiar, Mark F. Gourley, & George C. Tsokos. (2002). Defective Production of Functional 98-kDa Form of Elf-1 Is Responsible for the Decreased Expression of TCR ζ-Chain in Patients with Systemic Lupus Erythematosus. The Journal of Immunology. 169(10). 6048–6055. 54 indexed citations
8.
Tenbrock, Klaus, Yuang‐Taung Juang, Mark F. Gourley, Madhusoodana P. Nambiar, & George C. Tsokos. (2002). Antisense Cyclic Adenosine 5′-Monophosphate Response Element Modulator Up-Regulates IL-2 in T Cells from Patients with Systemic Lupus Erythematosus. The Journal of Immunology. 169(8). 4147–4152. 81 indexed citations
9.
Herndon, Thomas M., Yuang‐Taung Juang, Elena E. Solomou, et al.. (2002). Direct Transfer of p65 into T Lymphocytes from Systemic Lupus Erythematosus Patients Leads to Increased Levels of Interleukin-2 Promoter Activity. Clinical Immunology. 103(2). 145–153. 42 indexed citations
10.
Solomou, Elena E., Yuang‐Taung Juang, Mark F. Gourley, Gary M. Kammer, & George C. Tsokos. (2001). Molecular Basis of Deficient IL-2 Production in T Cells from Patients with Systemic Lupus Erythematosus. The Journal of Immunology. 166(6). 4216–4222. 164 indexed citations
11.
Illei, Gabor G., Howard A. Austin, Marianna Crane, et al.. (2001). Combination Therapy with Pulse Cyclophosphamide plus Pulse Methylprednisolone Improves Long-Term Renal Outcome without Adding Toxicity in Patients with Lupus Nephritis. Annals of Internal Medicine. 135(4). 248–257. 333 indexed citations
12.
Gourley, P. L. & Mark F. Gourley. (2000). Biocavity lasers for biomedicine. Trends in biotechnology. 18(11). 443–448. 6 indexed citations
13.
14.
Gourley, P. L., et al.. (1995). Surface-emitting semiconductor laser spectroscopy and microscopy for characterizing normal and sickled red blood cells. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 2387. 148–148. 4 indexed citations
15.
Krieg, Arthur Μ., Mark F. Gourley, Dennis M. Klinman, András Perl, & Alfred D. Steinberg. (1992). Heterogeneous Expression and Coordinate Regulation of Endogenous Retroviral Sequences in Human Peripheral Blood Mononuclear Cells. AIDS Research and Human Retroviruses. 8(12). 1991–1998. 38 indexed citations
16.
Gourley, Mark F., et al.. (1992). Molecular Aspects of Systemic Lupus Erythematosus: Murine Endogenous Retroviral Expression. DNA and Cell Biology. 11(3). 253–257. 8 indexed citations
17.
Krieg, Arthur Μ., et al.. (1991). Uptake of Oligodeoxyribonucleotides by Lymphoid Cells Is Heterogeneous and Inducible. PubMed. 1(2). 161–171. 81 indexed citations
18.
Steinberg, Alfred D., Arthur Μ. Krieg, Mark F. Gourley, & Dennis M. Klinman. (1990). Theoretical and Experimental Approaches to Generalized Autoimmunity. Immunological Reviews. 118(1). 129–163. 65 indexed citations
19.
Gourley, Mark F., Glenn R. Gourley, Enid F. Gilbert, & Gerard B. Odell. (1989). α1-Antitrypsin Deficiency and the PiMS Phenotype. Journal of Pediatric Gastroenterology and Nutrition. 8(1). 116–121. 8 indexed citations
20.
Gourley, Glenn R., Mark F. Gourley, Richard Arend, & Mari Palta. (1989). The Effect of Saccharolactone on Rat Intestinal Absorption of Bilirubin in the Presence of Human Breast Milk. Pediatric Research. 25(3). 234–238. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruud J.T. Smeenk Breakdown of academic impact, for papers by Yair Molad Breakdown of academic impact, for papers by Tomonori Ishii Breakdown of academic impact, for papers by Arthur I. Grayzel Breakdown of academic impact, for papers by G. Hauptmann Breakdown of academic impact, for papers by Woodruff Emlen Breakdown of academic impact, for papers by Damian Kraus Breakdown of academic impact, for papers by Federico Pratesi Breakdown of academic impact, for papers by Hiroaki Ida Breakdown of academic impact, for papers by Carlos Alberto von Mühlen
Rankless by CCL
2026